[1] Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391): 1145-1147.
[2] Takahashi K,Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
[3] Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA. 1998;9(5):13726-1373.
[4] Kiskinis E,Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest. 2010; 120(1):51-59.
[5] Ronaghi M, Erceg S, Moreno-Manzano V, et al. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells. 2010;28(1):93-99.
[6] Evans MJ,Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819):154-156.
[7] Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000;227(2): :271-278.
[8] Chambers I,Colby D,Robertson M, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113(5):643-655.
[9] Carpenter MK,Rosler E,Rao MS. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells. 2003;5(1):79-88.
[10] Reubinoff BE,Pera MF,Fong CY, et al. Embryonic stem cell lines from human blastocysts:somatic differentiation in vitro. Nat Biotechnol. 2000;18(4):399-404.
[11] Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest. 2010;120(1):51-59.
[12] Raya A,Rodriguez-Piza I,Navarro S, et al. A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc. 2010;5(4): 647-660.
[13] Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle. 2010; 9(5): 880-885.
[14] Baust JG,Gao D,Baust JM. Cryopreservation: An emerging paradigm change. Organogenesis. 2009;5(3):90-96.
[15] Meryman HT. Cryopreservation of living cells: principles and practice. Transfusion. 2007;47(5):935-945.
[16] Hubel A. Parameters of cell freezing: implications for the cryopreservation of stem cells.Transfus Med Rev. 1997;11(3): 224-233.
[17] Berz D, McCormack EM, Winer ES, et al. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007;82(6): 463-472.
[18] Reubinoff BE, Pera MF, Vajta G., et al. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod. 2001;16(10): 2187-2194.
[19] Richards M, Fong CY, Tan S, et al. An efficient and safe xeno-free cryopreservation method for the storage of human embryonic stem cells. Stem Cells. 2004;22(5):779-789.
[20] Vajta G., Holm P, Kuwayama M, et al. Open Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos. Mol Reprod Dev. 1998;51(1):53-58.
[21] Vajta G, Holm P, Greve T, et al. Survival and development of bovine blastocysts produced in vitro after assisted hatching, vitrification and in-straw direct rehydration. J Reprod Fertil. 1997;111(1):65-70.
[22] Hunt CJ, Timmons PM. Cryopreservation of human embryonic stem cell lines. Methods Mol Biol. 2007;368: 261-270.
[23] Li Y, Tan JC, Li LS. Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil Steril. 2010;93(3):999-1005.
[24] Zhou CQ, Mai QY, Li T, et al. Cryopreservation of human embryonic stem cells by vitrification. Chin Med J. 2004; 117(7): 1050-1055
[25] Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online. 2006;12(6):779-796.
[26] Lee JY, Lee JE, Kim DK, et al. High concentration of synthetic serum, stepwise equilibration and slow cooling as an efficient technique for large-scale cryopreservation of human embryonic stem cells. Fertil Steril. 2010; 93(3):976-985.
[27] Muldrew K,McGann LE. The osmotic rupture hypothesis of intracellular freezing injury. Biophys J. 1994;66(2):532-541.
[28] Schneider U,Maurer RR. Factors affecting survival of frozen-thawed mouse embryos. Biol Reprod. 1983;29(1): 121-128.
[29] Mazur P, Schneider U. Osmotic responses of preimplantation mouse and bovine embryos and their cryobiological implications. Cell Biophys. 1986;8(4):259-285.
[30] Fujikawa S. Freeze-fracture and etching studies on membrane damage on human erythrocytes caused by formation of intracellular ice. Cryobiology. 1980;17(4): 351-362.
[31] Mazur P, Cole KW. Roles of unfrozen fraction, salt concentration, and changes in cell volume in the survival of frozen human erythrocytes. Cryobiology. 1989;26(1):1-29.
[32] Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247(3):C125-C142.
[33] Ware CB, Nelson AM, Blau CA. Controlled-rate freezing of human ES cells. Biotechniques. 2005;38(6):879-880, 882-883.
[34] Yang PF, Hua TC, Wu J, et al. Cryopreservation of human embryonic stem cells: a protocol by programmed cooling. Cryo Letters. 2006;27(6):361-368.
[35] Wang HY, Lun ZR, Lu SS. Cryopreservation of umbilical cord blood-derived mesenchymal stem cells without dimethyl sulfoxide. Cryo Letters. 2011;32(1):81-88.
[36] Karlsson JO, Toner M. Long-term storage of tissues by cryopreservation: critical issues. Biomaterials. 1996;17(3): 243-256.
[37] Karlsson JO. Cryopreservation: freezing and vitrification. Science. 2002;296(5568):655-656.
[38] Katkov II, Kan NG, Cimadamore F. et al. DAmano M, Chihara K, Kimura K, et al.Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science. 1997;275(5304):1308-1311.
[41] Maekawa M, Ishizaki T, Boku S, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285(5429):895-898.
[42] Krawetz RJ, Li X, Rancourt DE. Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays. 2009;31(3):336-343.
[43] Watanabe K, Ueno M, Kamiya D, et al .A ROCK inhibitor permits survival of dissociated human embryonic stem cells.Nat Biotechnol. 2007;25(6):681-686.
[44] Li X, Meng G, Krawetz R, et al. The ROCK inhibitorY-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells. 2008;17(6):1079- 1085.
[45] Martin-Ibanez R, Unger C, Stromberg A, et al. Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. Hum Reprod. 2008;23(12):2744-2754.
[46] Claassen DA, Desler MM, Rizzino A. ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Mol Reprod. 2009;76(8):722-732.
[47] Mollamohammadi S, Taei A, Pakzad M, et al. A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. Hum Reprod.2009;24(10):2468-2476.
[48] Miyazaki T, Nakatsuji N, Suemori H. Optimization of slow cooling cryopreservation for human pluripotent stem cells. Genesis.2013;19(1002):22725.
[49] Xu X, Cowley S, Flaim CJ, et al. Enhancement of cell recovery for dissociated humanembryonic stem cells after cryopreservation. Biotechnol. 2010;26(3):781-788.
[50] Xu X, Cowley S, Flaim CJ, et al. The roles of apoptotic pathways in the low recovery rate after cryopreservation of dissociated human embryonic stem cells. Biotechnol. 2010; 26(3):827-837.
[51] Li X, Meng G., Krawetz R, et al.The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells. 2008;17(6): 1079-1085.
[52] Li X, Krawetz R, Liu S, et al. ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells. Hum Reprod. 2009;24(3):580-589.
[53] Hu E, Lee D. Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges. Expert Opin Ther Targets. 2005;9(4):715-736.
[54] Ji L, de Pablo JJ, Palecek SP. Cryopreservation of adherent human embryonic stem cells. Biotechnol Bioeng. 2004;88(3): 299-312.
[55] Nie Y, Bergendahl V, Hei DJ, et al. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog. 2009;25(1):20-31.
[56] T'Joen V, De Grande L, Declercq H, et al. An efficient, economical slow-freezing method for large-scale human embryonic stem cell banking. Stem Cells Dev. 2012;21(5): 721-728. [57] Holm F, Strom S, Inzunza J, et al. An effective serum- and xeno-free chemically defined freezin procedure for human embryonic and induced pluripotent stem cells. Hum Reprod. 2010;25(5):1271-1279.
[58] Beier AF, Schulz JC, Zimmermann H. Cryopreservation with a twist - towards a sterile, serum-free surface-based vitrification of hESCs. Cryobiology. 2013;66(3):256-260. |